Evidence map›Paper›PMID 11078525›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2000

A chemical genomics approach toward understanding the global functions of the target of rapamycin protein (TOR).

T F Chan, J Carvalho, L Riles, X F Zheng

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 81 papers.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

81 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. International journal of molecular sciences · 2022
    Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

T F ChanDepartments of Pathology and Immunology and Genetics, Washington University School of Medicine, St. Louis, MO 63110, USA.
J Carvalho
L Riles
X F Zheng

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The target of rapamycin protein (TOR) is a highly conserved ataxia telangiectasia-related protein kinase essential for cell growth. Emerging evidence indicates that TOR signaling is highly complex and is involved in a variety of cellular processes. To understand its general functions, we took a chemical genomics approach to explore the genetic interaction between TOR and other yeast genes on a genomic scale. In this study, the rapamycin sensitivity of individual deletion mutants generated by the Saccharomyces Genome Deletion Project was systematically measured. Our results provide a global view of the rapamycin-sensitive functions of TOR. In contrast to conventional genetic analysis, this approach offers a simple and thorough analysis of genetic interaction on a genomic scale and measures genetic interaction at different possible levels. It can be used to study the functions of other drug targets and to identify novel protein components of a conserved core biological process such as DNA damage checkpoint/repair that is interfered with by a cell-permeable chemical compound.

Indexed as

Gene Expression Regulation, FungalGenomicsPhosphatidylinositol 3-KinasesSaccharomyces cerevisiae ProteinsTranscription, GeneticCell Cycle ProteinsFungal ProteinsHumansMicrobial Sensitivity TestsMicrotubulesPhosphotransferases (Alcohol Group Acceptor)Protein KinasesRibosomal ProteinsSaccharomyces cerevisiaeSirolimusTOR Serine-Threonine KinasesCell Cycle ProteinsFungal ProteinsMTOR protein, humanPhosphatidylinositol 3-KinasesPhosphotransferases (Alcohol Group Acceptor)Protein KinasesRibosomal ProteinsSaccharomyces cerevisiae ProteinsSirolimusTOR1 protein, S cerevisiaeTOR2 protein, S cerevisiaeTOR Serine-Threonine KinasesUbiquitins

Identifiers

PMID11078525
PMCPMC27207

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.